111

BIONET CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.70 B‬TWD
‪78.40 M‬TWD
‪1.13 B‬TWD
‪43.97 M‬
Beta (1Y)
0.74

About BIONET CORP


CEO
Tien Lai Liu
Headquarters
Taipei
Founded
2000
ISIN
TW0001784007
FIGI
BBG000QQCB05
Bionet Corp. engages in the businesses of cell therapy, regenerative medicine and medical big data. Its services and products include cell storage & application services, prenatal testing, and biotechnology medical beauty care products. The company was founded on August 17, 2000 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 1784 is 92.8 TWD — it has decreased by −0.54% in the past 24 hours. Watch BIONET CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BIONET CORP stocks are traded under the ticker 1784.
1784 stock has risen by 4.98% compared to the previous week, the month change is a −5.11% fall, over the last year BIONET CORP has showed a 70.47% increase.
1784 reached its all-time high on Jul 19, 2024 with the price of 162.0 TWD, and its all-time low was 13.9 TWD and was reached on Feb 8, 2006. View more price dynamics on 1784 chart.
See other stocks reaching their highest and lowest prices.
1784 stock is 1.08% volatile and has beta coefficient of 0.74. Track BIONET CORP stock price on the chart and check out the list of the most volatile stocks — is BIONET CORP there?
Today BIONET CORP has the market capitalization of ‪4.72 B‬, it has increased by 7.36% over the last week.
Yes, you can track BIONET CORP financials in yearly and quarterly reports right on TradingView.
BIONET CORP is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
1784 net income for the last quarter is ‪11.63 M‬ TWD, while the quarter before that showed ‪16.80 M‬ TWD of net income which accounts for −30.79% change. Track more BIONET CORP financial stats to get the full picture.
Yes, 1784 dividends are paid annually. The last dividend per share was 0.71 TWD. As of today, Dividend Yield (TTM)% is 0.67%. Tracking BIONET CORP dividends might help you take more informed decisions.
BIONET CORP dividend yield was 1.14% in 2023, and payout ratio reached 39.77%. The year before the numbers were 1.59% and 86.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONET CORP EBITDA is ‪95.88 M‬ TWD, and current EBITDA margin is 11.03%. See more stats in BIONET CORP financial statements.
Like other stocks, 1784 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONET CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONET CORP technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONET CORP stock shows the buy signal. See more of BIONET CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.